Answers are grounded in this paper and cite their sources.
The mechanisms underlying ETR are multiple and characterized by diverse changes in both somatic genetic and transcriptomic profiles; to overcome resistance will require an individualized approach utilizing genomic and genetic biomarkers and drugs tailored to each patient.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: